CHEMOMAB THERAPEUTICS LTD. [•] American Depositary Shares [•] Warrants UNDERWRITING AGREEMENTUnderwriting Agreement • February 21st, 2023 • Chemomab Therapeutics Ltd. • Pharmaceutical preparations
Chemomab Therapeutics Ltd., a company organized and existing under the laws of the State of Israel (the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters (the “Underwriters”) named on Schedule I to this Underwriting Agreement (this “Agreement”), for whom you are acting as Representative (the “Representative”), an aggregate of (i) [•] American Depositary Shares (the “Shares”), each representing 20 ordinary shares, no par value per share, of the Company (the “Ordinary Shares” and the American Depositary Shares, the “ADSs”) and (ii) [•] warrants, each warrant exercisable for one ADS at an exercise price of $[•] per ADS with a term of five years, in the form attached hereto as Exhibit A (the “Warrants”). The respective amounts of the Shares and Warrants to be purchased by each of the several Underwriters are set forth opposite their names on Schedule I hereto.
